Evaluation of in vitro metabolic systems for common drugs of abuse. 1. Cocaine

References

• Brandon EFA, Raap CD, Meijerman I, et al. (2003). An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol Appl Pharmacol 189:233–46
   PubMed Web of Science ®Google Scholar
• Brzezinski MR, Spink BJ, Dean RA, et al. (1997). Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. Drug Metab Dispos 25:1089–96
   PubMed Web of Science ®Google Scholar
• da Costa JL, Tonin FG, Zanolli LA, et al. (2009). Simple method for determination of cocaine and main metabolites in urine by CE coupled to MS. Electrophoresis 30:2238–44
   PubMed Web of Science ®Google Scholar
• Dowers TS, Rock DA, Rock DA, et al. (2004). An analysis of the regioselectivity of aromatic hydroxylation and N-oxygenation by cytochrome P450 enzymes. Drug Metab Dispos 32:328–32
   PubMed Web of Science ®Google Scholar
• Erve JCL. (2006). Chemical toxicology: reactive intermediates and their role in pharmacology and toxicology. Expert Opin Drug Metab Toxicol 2:923–46
   PubMed Web of Science ®Google Scholar
• Evans DC, Watt AP, Nicoll-Griffith DA, et al. (2005). Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem Res Toxicol 17:3–16
   Web of Science ®Google Scholar
• Fandino AS, Toennes SW, Kauert GF. (2002). Studies on hydrolytic and oxidative metabolic pathways of anhydroecgonine methyl ester (methylecgonidine) using microsomal preparations from rat organs. Chem Res Toxicol 15:1543–8
   PubMed Web of Science ®Google Scholar
• Fisher MB, Campanale K, Ackermann BL, et al. (2000). In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metab Dispos 28:560–6
   PubMed Web of Science ®Google Scholar
• Ge LY, Yong JWH, Tan SN, et al. (2005). Analysis of positional isomers of hydroxylated aromatic cytokinins by micellar electrokinetic chromatography. Electrophoresis 26:1768–77
   PubMedGoogle Scholar
• Greene N, Naven R. (2009). Early toxicity screening strategies. Curr Opin Drug Disc 12:90–7
   PubMed Web of Science ®Google Scholar
• Guengerich FP. (2008). Oxidative, reductive, and hydrolytic metabolism of drugs. In: Zhang D, Zhu M, Humphreys WG, ed. Drug metabolism in drug design and development: basic concepts and practice. Hoboken: John Wiley & Sons, Inc., 15–35
   Google Scholar
• Guo J, Zhou DS, Grimm SW. (2011). Liquid chromatography-tandem mass spectrometry method for measurement of nicotine N-glucuronide: a marker for human UGT2B10 inhibition. J Pharm Biomed Anal 55:964–71
   PubMed Web of Science ®Google Scholar
• Isenschmid D. (2006). Cocaine. In: Levine B, ed. Principles of forensic toxicology. Washington, DC: AACC Press, 239–60
   Google Scholar
• Isenschmid DS, Fischman MW, Foltin RW, et al. (1992). Concentration of cocaine and metabolites in plasma of humans following intravenous administration and smoking of cocaine. J Anal Toxicol 16:311–4
   PubMed Web of Science ®Google Scholar
• Isenschmid DS, Levine BS, Caplan YH. (1989). A comprehensive study of the stability of cocaine and its metabolites. J Anal Toxicol 13:250–6
   PubMed Web of Science ®Google Scholar
• Jagerdeo E, Montgomery MA, Lebeau MA, et al. (2008). An automated SPE/LC/MS/MS method for the analysis of cocaine and metabolites in whole blood. J Chromatogr, B: Anal Technol Biomed Life Sci 874:15–20
   PubMed Web of Science ®Google Scholar
• Kaminsky LS, Zhang ZY. (1997). Human P450 metabolism of warfarin. Pharmacol Ther 73:67–74
   PubMed Web of Science ®Google Scholar
• Kanamori T, Kuwayama K, Tsujikawa K, et al. (2011). A model system for prediction of the in vivo metabolism of designer drugs using three-dimensional culture of rat and human hepatocytes. Forensic Toxicol 29:142–51
   Web of Science ®Google Scholar
• Kerns EH, Di L. (2008). Drug-like properties: concepts, structure design and methods: from ADME to toxicity optimization. New York: Elsevier, Inc., 329–47
   Google Scholar
• Kloss MW, Rosen GM, Rauckman EJ. (1983). N-Demethylation of cocaine to norcocaine: evidence for participation by cytochrome P-450 and FAD-containing monooxygenase. Mol Pharmacol 23:482–5
   PubMed Web of Science ®Google Scholar
• Laizure SC, Mandrell T, Gades NM, et al. (2003). Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases. Drug Metab Dispos 31:16–20
   PubMed Web of Science ®Google Scholar
• Li P, Zhao K, Deng SX, et al. (1999). Nonenzymatic hydrolysis of cocaine via intramolecular acid catalysis. Helv Chim Acta 82:85–9
   Web of Science ®Google Scholar
• Lightfoot T, Ellis SW, Mahling J, et al. (2000). Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modelling. Xenobiotica 30:219–33
   PubMed Web of Science ®Google Scholar
• Mitchell MD, Elrick MM, Walgren JL, et al. (2008). Peptide-based in vitro assay for the detection of reactive metabolites. Chem Res Toxicol 21:859–68
   PubMed Web of Science ®Google Scholar
• Monsarrat B, Thoison O, Dubois J, et al. (2009). Molecular determinant of regioselective hydroxylation of docetaxel by CYP3A4. Mol Cell Pharmacol 1:76–84
   Google Scholar
• Park BK, Kitteringham NR, Maggs JL, et al. (2005). The role of metabolic activation in drug-induced hepatotoxicity. Annu Rev Pharmacol Toxicol 45:177–202
   PubMed Web of Science ®Google Scholar
• Peters FT, Meyer MR. (2011). In vitro approaches to studying the metabolism of new psychoactive compounds. Drug Test Anal 3:483–95
   PubMed Web of Science ®Google Scholar
• Pindel EV, Kedishvili NY, Abraham TL, et al. (1997). Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin. J Biol Chem 272:14769–75
   PubMed Web of Science ®Google Scholar
• Porter WR. (2010). Warfarin: history, tautomerism and activity. J Comput Aided Mol Des 24:553–73
   PubMed Web of Science ®Google Scholar
• Roberts SM, Harbison RD, James RC. (1991). Human microsomal N-oxidative metabolism of cocaine. Drug Metab Dispos 19:1046–51
   PubMed Web of Science ®Google Scholar
• Smirnow D, Logan BK. (1996). Analysis of ecgonine and other cocaine biotransformation products in postmortem whole blood by protein precipitation-extractive alkylation and GC-MS. J Anal Toxicol 20:463–7
   PubMed Web of Science ®Google Scholar
• Somers G, Mutch P, Woodrooffe A. (2004). In vitro techniques for investigating drug metabolism. In: Evans G, ed. A handbook of bioanalysis and drug metabolism. Boca Raton, FL: CRC Press, 244–68
   Google Scholar
• Terry C, Mitry RR, Lehec SC, et al. (2005). The effects of cryopreservation on human hepatocytes obtained from different sources of liver tissue. Cell Transplantation 14:585–94
   PubMed Web of Science ®Google Scholar
• Tieleman DP, Berendsen HJC, Sansom MSP. (1999). An alamethicin channel in a lipid bilayer: molecular dynamics simulations. Biophys J 76:1757–69
   PubMed Web of Science ®Google Scholar
• Toennes SW, Thiel M, Walther M, et al. (2003). Studies on metabolic pathways of cocaine and its metabolites using microsome preparations from rat organs. Chem Res Toxicol 16:375–81
   PubMed Web of Science ®Google Scholar
• Troutman JA, Foertsch LM, Kern PS, et al. (2011). The incorporation of lysine into the peroxidase peptide reactivity assay for skin sensitization assessments. Toxicol Sci 122:422–36
   PubMed Web of Science ®Google Scholar
• von Moltke LL, Greenblatt DJ, Granda BW, et al. (1999). Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations. Br J Clin Pharmacol 48:89–97
   PubMed Web of Science ®Google Scholar
• Walgren JL, Mitchell MD, Thompson DC. (2005). Role of metabolism in drug-induced idiosyncratic hepatotoxicity. Crit Rev Toxicol 35:325–61
   PubMed Web of Science ®Google Scholar
• Wang PP, Bartlett MG. (1998). Collision-induced dissociation mass spectra of cocaine, and its metabolites and pyrolysis products. J Mass Spectrom 33:961–7
   Web of Science ®Google Scholar
• White RE, Groves JT, Mcclusky GA. (1979). Electronic and steric factors in regioselective hydroxylation catalyzed by purified cytochrome-P-450. Acta Biologica et Medica Germanica 38:475–482
   PubMedGoogle Scholar
• Yamazaki H, Ueng YF, Shimada T, et al. (1995). Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome-P450 3A4 and replacement of NADPH-cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates. Biochemistry 34:8380–9
   PubMed Web of Science ®Google Scholar
• Yao D, Shi XL, Wang L, et al. (2013). Characterization of differential cocaine metabolism in mouse and rat through metabolomics-guided metabolite profiling. Drug Metab Dispos 41:79–88
   PubMed Web of Science ®Google Scholar
• Zhang JY, Foltz RL. (1990). Cocaine metabolism in man: Identification of four previously unreported cocaine metabolites in human urine. J Anal Toxicol 14:201–5
   PubMed Web of Science ®Google Scholar